FDA Inspection 1190656 — Medicap Laboratories
The FDA completed an inspection of Medicap Laboratories on Sep 26, 2022 in Etobicoke. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 26, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Etobicoke (Canada)